[ad_1]
SOURCES:
Brenda Avadian, Pearblossom, CA.
Maria C. Carrillo, PhD, Alzheimer's Association, Chicago.
Jill Hofstede, Brush Prairie, WA.
Clifford R. Jack Jr., MD, Mayo Clinic, Rochester, MN.
Walter J. Koroshetz, MD, director, National Institute of Neurological Diseases and Disorders, National Institutes of Health, Bethesda, MD.
Gil Rabinovici, MD, Memory and Aging Center of the University of California at San Francisco (UCSF).
Journal of the American Medical Association: "Association of Amyloid Positron Emission Tomography and a Subsequent Change in Clinical Management in Medicare Recipients with Mild Cognitive Impairment or Dementia", "Amyloid PET and Clinical Management Modifications in Patients with Disease" a cognitive impairment
Alzheimer's Association: "Facts and Figures", "Facts and Figures on Alzheimer's Disease in 2019".
The voice of caregivers.
Society of Nuclear Medicine and Molecular Imaging: "Criteria for Appropriate Use".
[ad_2]
Source link